SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001720725-21-000075
Filing Date
2021-08-05
Accepted
2021-08-05 16:14:51
Documents
56
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q oyst-20210630.htm   iXBRL 10-Q 920867
2 EX-10.1 oyst-q2x21ex101.htm EX-10.1 236052
3 EX-10.2 oyst-q221ex102.htm EX-10.2 57052
4 EX-10.3 oyst-q2x21ex103.htm EX-10.3 40511
5 EX-31.1 oyst-q2x21ex311.htm EX-31.1 12615
6 EX-31.2 oyst-q2x21ex312.htm EX-31.2 12628
7 EX-32.1 oyst-q2x21ex321.htm EX-32.1 7319
8 EX-32.2 oyst-q2x21ex322.htm EX-32.2 7872
14 image_0a.jpg GRAPHIC 161
  Complete submission text file 0001720725-21-000075.txt   4964198

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oyst-20210630.xsd EX-101.SCH 34226
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT oyst-20210630_cal.xml EX-101.CAL 66399
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT oyst-20210630_def.xml EX-101.DEF 110527
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oyst-20210630_lab.xml EX-101.LAB 475139
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oyst-20210630_pre.xml EX-101.PRE 281306
15 EXTRACTED XBRL INSTANCE DOCUMENT oyst-20210630_htm.xml XML 687930
Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Filer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39112 | Film No.: 211148360
SIC: 2836 Biological Products, (No Diagnostic Substances)